MorphoSys Announces Presentations at Upcoming American Society of Hematology Annual Meeting 2015
05 nov. 2015 10h57 HE
|
MorphoSys AG
MARTINSRIED and MUNICH, Germany, Nov. 5, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX, OTC: MPSYY) today announced upcoming presentations of data on the Company's...
MorphoSys AG Reports Results for the First Nine Months of 2015
04 nov. 2015 01h06 HE
|
MorphoSys AG
MARTINSRIED and MUNICH, Germany, Nov. 4, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX, OTC: MPSYY) today announced its financial results for the nine months ending...
MorphoSys Announces Clinical Milestone in Hemophilia Program with Bayer HealthCare
30 oct. 2015 02h33 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, Oct. 30, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) announced today that it has received a milestone payment from Bayer...
MorphoSys to Host Q3 2015 Conference Call on November 4, 2015
28 oct. 2015 10h25 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, Oct. 28, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first nine months' 2015 results on November 4, 2015 at 7:00 am...
MorphoSys Publishes Update on MOR202 in Multiple Myeloma at 15th International Myeloma Workshop
23 sept. 2015 01h42 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, Sept. 23, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) today published updated safety and preliminary efficacy data on...
MorphoSys Provides an Update on its Proprietary Development Portfolio
08 sept. 2015 01h40 HE
|
MorphoSys AG
Lead Cancer Program MOR208 to be Examined in Numerous Combination Studies in Hematological Cancers
Conference call and webcast (in English) today at 2:00pm CEST (1:00pm BST/8:00am...
MorphoSys to Present at Six Upcoming Conferences
04 sept. 2015 08h08 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, Sept. 4, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) will present at the following conferences:
Commerzbank Sector...
MorphoSys and Immatics Biotechnologies Enter Strategic Alliance in Immuno-oncology
25 août 2015 01h42 HE
|
MorphoSys AG
MARTINSRIED, Germany, Aug. 25, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and Immatics Biotechnologies GmbH announced today a strategic alliance to...
MorphoSys and G7 Therapeutics Sign Alliance to Develop Innovative Antibody Therapeutics
04 août 2015 01h35 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, Aug. 4, 2015 (GLOBE NEWSWIRE) -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX, OTC: MPSYY) and G7 Therapeutics AG announced today that they have signed an...
MorphoSys's Partner Heptares Initiates Proprietary Therapeutic Antibody Program against a GPCR Target
30 juil. 2015 01h44 HE
|
MorphoSys AG
MARTINSRIED / MUNICH, Germany, July 30, 2015 (GLOBE NEWSWIRE) -- Successful Discovery Alliance Combines Two Leading Technologies
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY)...